ArticleRespiratory research2022

Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap.

Joseph Emil Amegadzie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.